A rare problem in a pregnant woman with COVID-19 pneumonia: Pneumomediastinum and subcutaneous emphysema | |
DOI: 10.5606/e-cvsi.2020.906 | |
Esra Sultan Karabulut Keklik1, Hakan Dal1, Şahin Bozok2 | |
1Department of Anesthesiology and Reanimation, Uşak University, Training and Research Hospital, Uşak, Turkey 2Department of Cardiovascular Surgery, Uşak University Faculty of Medicine, Uşak, Turkey |
|
Keywords: Complication, computed tomography, coronavirus, COVID-19, pneumomediastinum, pneumonia, pregnant woman | |
Novel coronavirus disease-2019 (COVID-19) has affected millions of individuals within in a short period of time, resulting in hundreds of
thousands of deaths, and has led to a crisis worldwide. A 22-year-old pregnant woman (32 weeks of gestation) was admitted to our clinic
with a suspicion of COVID-19. Initially, radiological evaluation using computed tomography (CT) imaging was unable to be performed,
as the patient refused imaging study; however, we were able to obtain CT following emergency cesarean section. On CT scan, pulmonary
lesions were predominant at the lower zones and progressed to confluent bilateral consolidation with pneumomediastinum, confirming
COVID-19 pneumonia and pneumomediastinum complications. In conclusion, although rare, spontaneous pneumomediastinum should
be considered in COVID-19 infection. |
|
Pneumomediastinum is classified as primary
(spontaneous) or secondary pneumomediastinum.[1,2]
There is no obvious underlying cause in spontaneous
mediastinum, while there is an apparent cause such
as trauma, intra-thoracic infection, and injuries of
respiratory or gastrointestinal tracts in the secondary
type. Majority of cases develop due to traumatic
causes.[1,2] Although spontaneous pneumomediastinum
is rare, it is often seen in healthy, young men as
a result of rupture of the peripheral pulmonary
alveoli.[1,2] Other potential causes include barotrauma
during mechanical ventilation, hyperbaric therapy,
elevation phase of diving, asthma or obstructive
airway, such as foreign body aspiration. In addition,
pneumomediastinum has been also reported following
tooth extraction, tonsillectomy, tracheostomy, head
and neck surgery, and craniofacial trauma.[1,2] In late December 2019, several pneumonia cases with an unknown etiology were reported from Wuhan Province of China and evolved to global pandemics. The causative agent was initially designated as acute respiratory distress syndrome-coronavirus-2 (SARS-CoV-2); subsequently, it was denoted as novel coronavirus disease-2019 by the World Health Organization (WHO).[3,4] Pulmonary parenchymal opacities are frequently seen on chest radiographs. Complications of severe COVID-19 pneumonia were reported in few cases.[5] In this article, we report a young pregnant woman with pneumomediastinum as a potential, rare complication of COVID-19 pneumonia. |
|
CASE PRESANTATION
|
|
A 22-year-old pregnant woman (32 weeks of
gestation) without a known systemic disease was
admitted to our clinic with fever. The patient refused
computed tomography (CT) imaging due to potential
harms of CT during pregnancy. She had no respiratory,
circulatory, or metabolic problem requiring intensive
care unit (ICU) admission and was admitted to the
pandemic clinic with suspected COVID-19. As the
polymerase chain reaction (PCR) test was positive,
a loading dose of hydroxychloroquine 400 mg b.i.d., followed by a maintenance dose of 200 mg b.i.d.
and a loading dose of azithromycin 500 mg b.i.d.,
followed by a maintenance dose of 250 mg b.i.d.
were prescribed based on the COVID-19 National
Treatment Guidelines. On Day 3 after admission,
the patient had hypoxemia (peripheral oxygen
saturation [sPO2]: 80%) and tachypnea (respiration
rate: 36/min); thus, she was admitted to the
pandemic ICU. In the first assessment in the ICU, the patient had dyspnea, severe tachypnea (respiration rate: 36/min) and tachycardia (heart rate: 130 bpm). The sPO2 value was 78% under oxygen supplementation (6 to 8 L/min) via the face mask. Non-invasive mechanical ventilation was initiated (via full-face mask; pressure-assisted ventilation mode; positive end expiratory pressure [PEEP]: 7 cmH2O and pressure support [PS]: 14 cmH2O; 50% oxygen supplementation). The sPO2 value was improved to 97% and tachypnea was decreased (respiration rate: 24/min). After ICU admission, high-flow nasal oxygen supplementation (37°C; 60 L/min flow and 40% oxygen) and interrupted non-invasive mechanical ventilation (50% oxygen; PEEP: 7 cmH2O; PS: 14 cmH2O; pressure-assisted ventilation mode, via an oronasal mask) were applied until Day 9. On Day 4 after the ICU admission, new-onset chest pain developed. Subcutaneous emphysema was palpated on the upper one-third of left thoracic wall, particularly over the clavicle. Chest auscultation findings were normal. The radiological chest imaging was planned to the patient; however, the patient refused any type of imaging study. Thus, lung sonography was planned to the patient. However, due to the settings of COVID-19 ICU and unfavorable general health status of the patient, an adequate assessment could not be performed. As there was no alteration in clinical findings, hypoxemia level and ventilation parameters, we continued to follow the patient with the available status. The patient was maintained by alternate ventilation strategy (5-h high-flow nasal oxygen followed by 1-h non-invasive mechanical ventilation; however, on Day 7, the need for non-invasive mechanical ventilation increased due to hypoxemia with a sPO2 of 85 to 90 cmH2<O); thus, a sonography was performed by an obstetrician, revealing the decreased amnion fluid. An emergency cesarean section was performed under spinal due to the decreased amnion fluid and profound hypoxemia anesthesia in the patient on non-invasive mechanical ventilation. Two PCR tests with a 24-h interval were negative for COVID-19 in the infant; thus, newborn was discharged after seven days of ICU admission. The CT imaging which was refused initially by the patient was performed after cesarean section and revealed multiple diffuse patchy consolidation areas and ground-glass opacities in both lungs and pneumomediastinum, confirming COVID-19 pneumonia, pneumomediastinum without pneumothorax and subcutaneous emphysema (Figure 1a-d). As pneumothorax was lacking and pneumomediastinum caused no compression, no surgery was planned. On Day 2 after cesarean section, orotracheal intubation was performed and mechanical ventilation was initiated due to worsening in the general health status and respiratory parameters on Day 9 after admission. The following parameters were used for ventilation: pressure-regulated volume control mode; tidal volume, 550 mL, frequency, 16/min, PEEP: 10 cmH2O and FiO2: 80%. Due to worsened gas exchange (P/F:70), the patient was placed to the prolonged prone position (22 h). On Day 14 after detection of pneumomediastinum on the first CT scan, a control CT imaging was performed in the patient who had deterioration in gas exchange, respiratory parameters, and hemodynamics and revealed massive pneumothorax in the left lung and disappearance of previous subcutaneous emphysema (Figure 2a, b). Thus, a chest tube was inserted via thoracostomy from the left side. During follow-up, Acinetobacter baumannii sepsis, deep venous thrombosis in the left femoral vein, and subsequent pulmonary embolism developed. The patient died on Day 22 after the ICU admission, despite all efforts. |
|
Pneumomediastinum is a rare entity. In previous
studies, the pneumomediastinum incidence has been
reported as 1:800 to 1:42,000 in children presented
to emergency department and 1:15,500 admissions
in general population. The mean age at onset is
19 years.[1,2] The pain is the most common presenting
symptom in 80 to 90% of patients.[1,2] In our case,
similarly, the first complaint in the ICU was chest pain. Computed tomography plays a major role in the diagnosis of COVID-19 pneumonia, which is an ongoing global problem. Although many parenchymal or non-parenchymal findings are seen on CT scans, the most common finding is ground-glass opacities in parenchyma.[6] Spontaneous pneumomediastinum is an extremely rare condition. The most common clinical findings include fever, cough, myalgia, or fatigue.[6] Our patient refused radiological evaluation due to potential harms of CT during pregnancy; thus, the diagnosis was made based on PCR testing and clinical presentation, and no radiological examination was able to be performed initially. Such findings should be addressed meticulously, particularly in the course of COVID-19 pneumonia. Thus, diagnosis through early imaging studies and timely treatment of COVID-19 complications can improve therapeutic effectiveness and decrease mortality.[5] Pneumothorax and pneumomediastinum have been rarely reported in COVID-19 pneumonia. The pneumomediastinum was not only observed without parenchymal lesion,[7] but also observed with ground-glass opacities, findings of pneumonia, and pulmonary parenchymal injury.[5,8] In our patient, pneumomediastinum was present with findings of COVID-19 pneumonia. In previous reports, there was no comorbid condition such as asthma or chronic lung disease which may contribute to available condition or invasive interventions leading to iatrogenic pneumothorax; therefore, all previous cases were considered COVID-19-related spontaneous pneumomediastinum.[5,7,8] Although pregnancy, itself, has been reported as a cause of spontaneous mediastinum,[1,2] we believe that severe, dry cough, and pulmonary injury caused by COVID-19 could be the cause of pneumomediastinum. Although severe pulmonary injury was seen in on the initial thoracic CT scan, it was thought that pneumomediastinum without pneumothorax was surprising. During pandemic, four pregnant women were treated in our hospital. All patients were treated in accordance with the COVID-19 National Treatment Guidelines. Of these patients, three women were discharged successfully; however, the present case died. In conclusion, although spontaneous pneumomediastinum is rarely seen in COVID-19 infection, it can develop due to severe cough and respiratory distress. Spontaneous pneumomediastinum is usually a self-limiting disorder, although the exact mechanism is still unknown. However, it has potential to cause severe circulatory or respiratory disorder. Thus, spontaneous pneumomediastinum in COVID-19 patients should be closely monitored as a potential marker for progression.
Declaration of conflicting interests
Funding |
|
1) Ichinose J, Nagayama K, Hino H, Nitadori J, Anraku
M, Murakawa T, et al. Results of surgical treatment
for secondary spontaneous pneumothorax according
to underlying diseases. Eur J Cardiothorac Surg
2016;49:1132-6.
2) Işık H, Sapmaz E, Özbey M, Çaylak H, Şengül İnan M.
A rare cause of pneumomediastinum and subcutaneous
emphysema: Tooth extraction. Turk Gogus Kalp Dama
2020;28:390-3.
3) Yilmaz Y, Kamer E. Planning and safety of surgical
operation in COVID-19 Pandemic. Ege Klin Tıp Derg
2020;58Supp:55-61.
4) Kamer E, Çolak T. What to do when a patient infected
with COVID-19 needs an operation: A pre-surgery, perisurgery
and post-surgery guide. Turk J Colorectal Dis
2020;30:1-8.
5) Sun R, Liu H, Wang X. Mediastinal Emphysema, Giant
Bulla, and Pneumothorax Developed during the Course
of COVID-19 Pneumonia. Korean J Radiol 2020;21:541-4.
6) Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al.
Coronavirus Disease 2019 (COVID-19): A Perspective from
China. Radiology 2020;296:E15-E25.
|
|